Current Assets: The sum of all assets that are classified as current, because they will provide a benefit within one year.
Travere Therapeutics, Inc. (TVTX) had Current Assets of $437.56M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$490.73M |
|
$-25.55M |
|
$10.34M |
|
$480.39M |
|
$553.55M |
|
$-62.82M |
|
$13.55M |
|
$-49.27M |
|
$-49.27M |
|
$-50.26M |
|
$-50.26M |
|
$-25.55M |
|
$-50.26M |
|
$-62.82M |
|
$-4.88M |
|
89.21M |
|
89.21M |
|
$-0.29 |
|
$-0.29 |
|
| Balance Sheet Financials | |
|
Current Assets |
$437.56M |
$4.02M |
|
$167.63M |
|
$605.19M |
|
$159.90M |
|
$311.72M |
|
$330.46M |
|
$490.36M |
|
$114.83M |
|
$0.96M |
|
$114.83M |
|
90.92M |
|
| Cash Flow Statement Financials | |
$37.78M |
|
$27.89M |
|
$-33.47M |
|
$58.53M |
|
$93.03M |
|
$34.50M |
|
$44.87M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.74 |
|
-- |
|
-- |
|
0.73 |
|
2.71 |
|
97.89% |
|
-12.80% |
|
-12.80% |
|
-0.99% |
|
-10.04% |
|
-5.21% |
|
$37.78M |
|
-- |
|
-- |
|
-- |
|
0.81 |
|
1.76 |
|
6.12 |
|
59.60 |
|
-43.77% |
|
-5235.65% |
|
-8.30% |
|
-11.78% |
|
$1.26 |
|
$0.42 |
|
$0.42 |
|